Cipla ramps up production of Remdesivir; Indian IT firms to see dip in revenues : News Reel: Business Today
Business Today
Loading...
 

Cipla ramps up production of Remdesivir; Indian IT firms to see dip in revenues

July 14, 2020

In wake of rising demand for antiviral drug Remdesivir used for coronavirus treatment, homegrown drug major Cipla has ramped up its capacity and that of its partner network to fill the demand-supply gap; The United States has the biggest COVID-19 testing programme in the world, better than big countries like Russia, China, India and Brazil, President Donald Trump said on Monday; The Indian IT services sector is likely to see up to 3 per cent contraction in its revenues in the financial year 2020-21. Watch this and more on News Blast.

Also Read: Auto sales crash over 40% in June, normalcy to return only by 2023-24, says SIAM



    More from this section